Andrew Berens
Stock Analyst at Leerink Partners
(4.88)
# 323
Out of 5,090 analysts
558
Total ratings
46.2%
Success rate
23.6%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $30 | $8.50 | +252.94% | 1 | Oct 20, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $40 | $13.75 | +190.91% | 1 | Sep 21, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $27 → $25 | $2.62 | +854.20% | 5 | Sep 18, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.7865 | +790.02% | 26 | Aug 7, 2026 | |
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $69.39 | -25.06% | 13 | Aug 6, 2026 | |
| INCY Incyte | Reiterated: Buy | $103 → $155 | $120.39 | +28.75% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | n/a | $30.55 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $28.32 | +41.24% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.14 | - | 28 | Jun 2, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $46 → $51 | $21.49 | +137.32% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $33 | $18.21 | +81.22% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $43 | $9.10 | +372.53% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $55 | $22.72 | +142.08% | 26 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $9.55 | +140.84% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.58 | +123.46% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $40 | $28.61 | +39.81% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $97 | $69.13 | +40.32% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $31.02 | +61.19% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $3.75 | n/a | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $31.96 | n/a | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.03 | n/a | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $2.62 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $18.35 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.47 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $7.86 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $370.33 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.96 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 | $6.19 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $0.38 | - | n/a | 25 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $178.80 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.68 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 → $25 | $3.37 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $10.76 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.47 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $10.44 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $92.57 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $6.97 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.7065 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.07 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $40.18 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.71 | n/a | 2 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $170.68 | n/a | 3 | Dec 1, 2014 |
Kazia Therapeutics
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $8.50
Upside: +252.94%
BlossomHill Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $40
Current: $13.75
Upside: +190.91%
BridgeBio Oncology Therapeutics
Sep 18, 2026
Rated: Buy
Price Target: $27 → $25
Current: $2.62
Upside: +854.20%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7865
Upside: +790.02%
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $69.39
Upside: -25.06%
Incyte
Aug 3, 2026
Reiterated: Buy
Price Target: $103 → $155
Current: $120.39
Upside: +28.75%
Agios Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.55
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $28.32
Upside: +41.24%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.14
Upside: -
Damora Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $46 → $51
Current: $21.49
Upside: +137.32%
May 15, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $18.21
Upside: +81.22%
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $9.10
Upside: +372.53%
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $22.72
Upside: +142.08%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $9.55
Upside: +140.84%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.58
Upside: +123.46%
Nov 19, 2025
Reiterated: Buy
Price Target: $24 → $40
Current: $28.61
Upside: +39.81%
Nov 17, 2025
Reiterated: Buy
Price Target: $70 → $97
Current: $69.13
Upside: +40.32%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $31.02
Upside: +61.19%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $3.75
Upside: n/a
Oct 21, 2025
Reiterated: Hold
Price Target: $30 → $33
Current: $31.96
Upside: n/a
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.03
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $33
Current: $2.62
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $18.35
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $3
Current: $2.47
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $9
Current: $7.86
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $370.33
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $1.96
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $18.00
Current: $6.19
Upside: n/a
Jun 11, 2025
Reiterated: Hold
Price Target: $1 → $0.38
Current: -
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $178.80
Upside: n/a
Dec 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $74.68
Upside: n/a
Feb 7, 2023
Reiterated: Buy
Price Target: $67 → $25
Current: $3.37
Upside: n/a
Feb 7, 2023
Reiterated: Hold
Price Target: $20 → $15
Current: $10.76
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: n/a
Current: $29.47
Upside: n/a
May 7, 2021
Reiterated: Hold
Price Target: $10
Current: $10.44
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Reiterated: Hold
Price Target: $23
Current: $92.57
Upside: n/a
Jul 14, 2017
Reiterated: Hold
Price Target: $16 → $8
Current: $6.97
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.7065
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.07
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $40.18
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $10.71
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $170.68
Upside: n/a